Source:http://linkedlifedata.com/resource/pubmed/id/17692101
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
4
|
| pubmed:dateCreated |
2007-9-14
|
| pubmed:abstractText |
Intestinal marginal zone B-cell lymphoma of the MALT type (I-MZL) is a relatively uncommon form of lymphoma. Twenty-seven patients with histologically-confirmed I-MZL were analyzed. The patients initially presented with abdominal pain (62.9%), and diarrhea (22.2%). The most common involved site was the ileo-caecal area (40.7%). Musshoff's stage I(E), II(E)1, II(E)2, III(E) and IV were present in 44%, 15%, 11%, 7.4% and 22% respectively. Sixty-three percent were in the low-risk group according to the Follicular Lymphoma International Prognostic Index. Complete response and partial response were achieved in 82% and 4% patients. The estimated 5-year overall survival (OS) and progression-free survival (PFS) rates were 86% and 54%. Stage > or = II(E)2 was determined to be a poor prognostic factor for PFS and OS. I-MZL commonly manifests in an early-stage, low-risk state and tends to respond well to local and systemic treatment with favorable prognosis. I-MZL tends to be an indolent disease - characterized by prolonged survival with frequent relapses, similarly to other site MZLs.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:status |
MEDLINE
|
| pubmed:month |
Oct
|
| pubmed:issn |
0902-4441
|
| pubmed:author |
pubmed-author:HwangIn GyuIG,
pubmed-author:KangHye JinHJ,
pubmed-author:KimHyo-JinHJ,
pubmed-author:KimJung HanJH,
pubmed-author:KimKihyunK,
pubmed-author:KimWon SeogWS,
pubmed-author:KoYoung HaeYH,
pubmed-author:KwonHyuk-ChanHC,
pubmed-author:LeeJae-HoonJH,
pubmed-author:NamEunmiE,
pubmed-author:OhSung YongSY,
pubmed-author:ParkYeon HeeYH,
pubmed-author:RyooBaek-YeolBY
|
| pubmed:issnType |
Print
|
| pubmed:volume |
79
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
287-91
|
| pubmed:meshHeading |
pubmed-meshheading:17692101-Adult,
pubmed-meshheading:17692101-Aged,
pubmed-meshheading:17692101-Aged, 80 and over,
pubmed-meshheading:17692101-Cecal Neoplasms,
pubmed-meshheading:17692101-Combined Modality Therapy,
pubmed-meshheading:17692101-Disease-Free Survival,
pubmed-meshheading:17692101-Female,
pubmed-meshheading:17692101-Follow-Up Studies,
pubmed-meshheading:17692101-Humans,
pubmed-meshheading:17692101-Ileal Neoplasms,
pubmed-meshheading:17692101-Lymphoma, B-Cell, Marginal Zone,
pubmed-meshheading:17692101-Male,
pubmed-meshheading:17692101-Middle Aged,
pubmed-meshheading:17692101-Neoplasm Staging,
pubmed-meshheading:17692101-Rare Diseases,
pubmed-meshheading:17692101-Recurrence,
pubmed-meshheading:17692101-Risk Factors,
pubmed-meshheading:17692101-Survival Rate
|
| pubmed:year |
2007
|
| pubmed:articleTitle |
Intestinal marginal zone B-cell lymphoma of MALT type: clinical manifestation and outcome of a rare disease.
|
| pubmed:affiliation |
Department of Internal Medicine, Dong-A University College of Medicine, Busan, Korea.
|
| pubmed:publicationType |
Journal Article
|